Skip to main content

Phospholipide und phospholipidbindende Proteine

  • Chapter
Hämostaseologie
  • 4471 Accesses

Zusammenfassung

Phospholipide gehören zur Familie der Membranlipide und bilden den Hauptbestandteil der zellulären Doppelmembran. Ihre spezifischen physikochemischen Eigenschaften erhalten sie durch einen hydrophilen Kopf- und einen lipophilen Schwanzteil. In den enzymatischen Gerinnungsreaktionen fungieren Phospholipide als reaktive Oberflächen und ermöglichen die Ausbildung der Multienzymkomplexe. Eine gestörte Interaktion einzelner Gerinnungsfaktoren mit Phospholipiden kann den Gerinnungsprozess inhibieren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Atsumi T, Koike T (2002) Clinical Relevance of antiprothrombin antibodies. Autoimmun Rev 1: 49–53

    Article  CAS  PubMed  Google Scholar 

  • Atsumi T, Ieko M, Bertolaccini ML et al. (2000) Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 43(9): 1982–1993

    Article  CAS  PubMed  Google Scholar 

  • Bizzaro N, Antico A, Musso M et al. (2005a). A prospective study of 1038 pregnancies on the predictive value of anti-Annexin V antibodies for fetal loss. Ann NY Acad Sci 1050: 348–356

    Article  CAS  PubMed  Google Scholar 

  • Bizzaro N, Tonutti E, Villalta D et al. (2005b) Prevalence and clinical correlation of anti-phospholipid binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 129(1): 61–68

    PubMed  Google Scholar 

  • Conrad K, Schößler W, Hiepe F (2007) Autoantikörper bei systemischen Autoimmunerkrankungen. Pabst Science Publishers, Lengerich

    Google Scholar 

  • Di Simone N, Castellani R, Caliandro D et al. (2001) Monoclonal anti-Annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 65: 1766–1770

    Article  PubMed  Google Scholar 

  • Galli M, Comfurius P, Maassen C et al. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544–1547

    Article  CAS  PubMed  Google Scholar 

  • Harris EN, Gharavi AE, Boey ML et al. (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2: 1211–1215

    Article  CAS  PubMed  Google Scholar 

  • Hasegawa M, Sato S, Yanaba K et al. (2004) Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis. Ann Rheum Dis 63: 1514–1517

    Article  CAS  PubMed  Google Scholar 

  • Hunt JE, Krilis SA (1994) The fifth domain of β2-glycoprotein I contains a phopholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol 152: 653–659

    CAS  PubMed  Google Scholar 

  • IUPAC (1977) The nomenclature of lipids (recommendations 1976), IUPAC-IUB-Commission on Biochemical Nomenclature. Europ J Bioche. 79: 11–21

    Article  Google Scholar 

  • Kaburaki J, Kuwana M, Yamamoto M et al. (1997) Clinical significance of anti-annexin V antibodies in patients with systemic Lupus erythematosus. Am J Hematol 54: 209–213

    Article  CAS  PubMed  Google Scholar 

  • Koike T (1994) Anticardiolipin antibodies and β2-glycoprotein I. Clin Immunol Immunpathol 72(2): 187–192

    Article  CAS  Google Scholar 

  • Koike T, Ichikawa K, Kasahara H et al. (1998) Epitopes on beta2-GPI recognized by anticardiolipin antibodies. Lupus 7(Suppl.2): 14–17

    Article  Google Scholar 

  • Levy RA, Gharavi AE, Sammaritano LR (1990) Fatty acid chain is a critical epitope for antiphospholipid antibody. J Clin Immunol 13(3): 141–145

    Article  Google Scholar 

  • Lölinger A (1959) Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematodes? Thromb Diath Haemorrh 3: 237–256

    Google Scholar 

  • Loizou S, McRea JD, Rudge AC et al. (1985) Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 62: 738–745

    CAS  PubMed  Google Scholar 

  • Matsuura ER, Igarashi Y, Fujimoto M et al. (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177–178

    Article  CAS  PubMed  Google Scholar 

  • Matsuura ER, Igarashi Y, Yasuda T et al. (1994) Anticardiolipin antibodies recognise β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179: 457–462

    Article  CAS  PubMed  Google Scholar 

  • McNeil HP, Simpson RF, Chesterman CN et al. (1990). Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2-Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87: 4120–4124

    Article  CAS  PubMed  Google Scholar 

  • Nojima J, Kuratsune H, Snehisa E et al. (2001) Association between the prevalence of antibodies to β2-glycoprotein I, prothrombin, protein C, protein S and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 47: 1008–1015

    CAS  PubMed  Google Scholar 

  • Rand JH, Wu X-X (2001) Antiphospholipid antibody-mediated interference with annexin-V anticoagulant activity. Hämostaseologie 21: 50–53

    CAS  Google Scholar 

  • Rand JH, Wu X-X (2004) Antibody-mediated interference with annexins in the antiphospholipid syndrome. Thromb Res 114: 383–389

    Article  CAS  PubMed  Google Scholar 

  • Rauch J, Tannenbaum M, Janoff S (1989) Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemostas 62(3): 892–896

    CAS  Google Scholar 

  • Roubey RAS, Eisenberg RA, Winfield JB (1994) Autoantibodies to β2-glycoprotein I: the role of antibody affinity and antigen density. Lupus 3: 314

    Google Scholar 

  • Stryer L (1991) Biochemie. Spektrum Akad. Verlag, Heidelberg, S 307

    Google Scholar 

  • Triplett DA (1992) Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 28: 211–215

    CAS  PubMed  Google Scholar 

  • von Landenberg P, Matthias T, Zaech J et al. (2003) Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 49: 51–56

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schößler, W. (2010). Phospholipide und phospholipidbindende Proteine. In: Pötzsch, B., Madlener, K. (eds) Hämostaseologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01544-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-01544-1_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-01543-4

  • Online ISBN: 978-3-642-01544-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics